Pharma and Healthcare

The pharmaceutical industry is a complex battlefield of strategic interactions between different kinds of players. Issues of high investment uncertainty, especially in (but not restricted to) R&D; strong regulatory influence; the importance of marketing and sales; and the complex interplay of many stakeholders creates tough challenges for executives in the pharmaceutical and healthcare industry.

Our process for the individual modelling of each stakeholder’s interests, combined with our quantitative approach to analyzing strategic interactions, provides suitable support for management decisions in these fields. We have been working in pharmaceuticals and healthcare since 2010.



Aspects we have dealt with in the Pharma and Healthcare industry

N

Lobbying

N

Commoditization

N

Patent expiration

N

Industry landscaping

N

Multi-brand strategy

N

Product substitution

N

Competitive positioning

N

Communication strategy

N

Repositioning strategy

N

Competitor overreaction

N

Defending from takeover

N

New product introduction

N

Maneuvering in a price war

N

Attacking the market leader

N

Using competitor price shield

N

Handling a dominant competitor

N

Reaction to patent infringement

N

Avoiding head-to-head competition

N

Handling an aggressive competitor

N

Market exit and pullback strategy

N

Regulatory strategy and approvals

N

Sales force allocation and budgeting

N

Competitive pricing: dynamic strategy

N

Product development and specification

N

Responding to a competitor’s new product

N

Product / technology licensing agreement

N

Defense / counter strategy against competitor move

N

Strategic market positioning and market segmentation

N

Competitor acquisition: assessing the implications for competitive dynamics

N

Negotiation strategy, preparation, and support / multiple party negotiation

N

Strategic alliances, joint ventures, and partnering: forming and ending them